Molly Coolican
Adult Medicine · Oneida, NYNPI 1821720939
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations.
Across 159 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$918
- AbbVie$595
- Johnson & Johnson$444
- Amgen$301
- Novartis$242
- Novo Nordisk$227
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,66594%
- Education$2346%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $918 |
| AbbVie | 32 | $595 |
| Johnson & Johnson | 14 | $444 |
| Amgen | 13 | $301 |
| Novartis | 10 | $242 |
| Novo Nordisk | 13 | $227 |
| Astellas Pharma US Inc | 5 | $182 |
| Lilly USA, LLC | 10 | $170 |
| GSK | 7 | $167 |
| Alk-abello, Inc | 4 | $110 |
| Pfizer | 6 | $104 |
| Tolmar, Inc. | 3 | $57 |
| Exact Sciences | 3 | $46 |
| IBSA Pharma Inc. | 2 | $38 |
| UCB, Inc. | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Shield Therapeutics Inc | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| LEO Pharma Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,899 in reported general payments places this provider in the 85th percentile of 101 adult medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 66 | $99,527 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 82 | $83,195 |
| EliquisApixaban | 78 | $79,421 |
| OzempicSemaglutide | 41 | $45,621 |
| MounjaroTirzepatide | 27 | $34,903 |
| TrulicityDulaglutide | 24 | $32,697 |
| JanuviaSitagliptin Phosphate | 30 | $32,118 |
| JardianceEmpagliflozin | 23 | $31,928 |
| RybelsusSemaglutide | 16 | $27,359 |
| XareltoRivaroxaban | 18 | $24,801 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $24,227 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 19 | $17,874 |
| VascepaIcosapent Ethyl | 23 | $12,791 |
| LinzessLinaclotide | 14 | $10,142 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 25 | $6,519 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $918 | $123,75398 claims |
| GSKTrelegy Ellipta | $167 | $83,19582 claims |
| PfizerEliquis | $104 | $79,42178 claims |
| Novo NordiskOzempic, Rybelsus | $227 | $72,98057 claims |
| Lilly USA, LLCMounjaro, Trulicity | $170 | $67,60051 claims |
| MerckJanuvia, Janumet Xr | $23 | $49,99249 claims |
| Boehringer IngelheimJardiance | $21 | $31,92823 claims |
| Johnson & JohnsonXarelto | $444 | $24,80118 claims |
| AbbVieLinzess, Synthroid | $595 | $13,44555 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 101 adult medicine providers in New York.
Other adult medicine in Oneida
- Michael AlaimoMalverne$18K
- Vipin OhriWarsaw$14K
- Yuqing ZhangFlushing$13K
- Chidambaranathan ChandrasekaranPatchogue$13K
- Adam CarpentieriMassapequa$11K
- Cary DanielBrooklyn$10K
- Janaki KanumilliMineola$9K
- Zeeshan KhanOceanside$9K
- Thomas MolnarJamaica$8K
- Tehmina NaveedPlainview$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.